✦ LIBER ✦

A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: A gynecologic oncology group study

✍ Scribed by D. Scott McMeekin; Michael W. Sill; Kathleen M. Darcy; Deborah J. Stearns-Kurosawa; Kenneth Webster; Steven Waggoner; Doris Benbrook

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of thalidomide in patie

✍ D. Scott McMeekin; Michael W. Sill; Doris Benbrook; Kathleen M. Darcy; Deborah J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB

A phase II trial of thalidomide in patie

✍ D. Scott McMeekin; Michael W. Sill; Kathleen M. Darcy; Ovadia Abulafia; Parviz H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II Trial of Etoposide in Leiomyosa

✍ Tate Thigpen; John A. Blessing; Edgardo Yordan; Fidel Valea; Luis Vaccarello 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Barrett, Rolland J.; McGehee, Ramon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Phase II trial of dacarbazine, mitomycin

✍ Harry J. Long III; John A. Blessing; Joel Sorosky 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB